{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T01:40:35Z","timestamp":1740706835050,"version":"3.38.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004374","name":"The First Affiliated Hospital of Chongqing Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jneuroim.2025.578549","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T16:17:11Z","timestamp":1738945031000},"page":"578549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Brain network alteration was associated with \u2018no evidence of disease activity\u2019 status in patients with relapsing-remitting multiple sclerosis"],"prefix":"10.1016","volume":"400","author":[{"given":"Zichun","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuowei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoya","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinzhou","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2025.578549_bb0005","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1162\/netn_a_00276","article-title":"Graph theoretical approach to brain remodeling in multiple sclerosis","volume":"7","author":"Abdolalizadeh","year":"2023","journal-title":"Network Neurosci. (Cambridge, Mass)."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0010","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/1352458519887324","article-title":"Precision medicine in the multiple sclerosis clinic: selecting the right patient for the right treatment","volume":"26","author":"Bose","year":"2020","journal-title":"Multiple Sclerosis (Houndmills, Basingstoke, England)."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0015","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nrn2575","article-title":"Complex brain networks: graph theoretical analysis of structural and functional systems","volume":"10","author":"Bullmore","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neuroscience.2024.08.031","article-title":"Functional connectivity differences of the olfactory network in Parkinson\u2019s disease, mild cognitive impairment and cognitively normal individuals: a resting-state fMRI study","volume":"559","author":"Cieri","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2025.578549_bb0025","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3389\/fneur.2018.01150","article-title":"The effect of disease modifying therapies on disability progression in multiple sclerosis: a systematic overview of meta-analyses","volume":"9","author":"Claflin","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fnhum.2013.00042","article-title":"PANDA: a pipeline toolbox for analyzing brain diffusion images","volume":"7","author":"Cui","year":"2013","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s40263-017-0415-2","article-title":"Effect of Fingolimod on brain volume loss in patients with multiple sclerosis","volume":"31","author":"De Stefano","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jneuroim.2025.578549_bb0040","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s00415-018-8791-1","article-title":"Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients","volume":"265","author":"Esposito","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuroscience.2017.10.033","article-title":"Graph theoretical framework of brain networks in multiple sclerosis: a review of concepts","volume":"403","author":"Fleischer","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2025.578549_bb0050","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1017\/cjn.2020.66","article-title":"Treatment optimization in multiple sclerosis: Canadian MS working group recommendations","volume":"47","author":"Freedman","year":"2020","journal-title":"Can. J. Neurol. Sci. Le journal canadien des sciences neurologiques."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0055","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1177\/1352458517703193","article-title":"\u201cNo evident disease activity\u201d: the use of combined assessments in the management of patients with multiple sclerosis","volume":"23","author":"Giovannoni","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0060","first-page":"2","article-title":"Baseline characteristics associated with NEDA-3 status in fingolimod-treated patients with relapsing-remitting multiple sclerosis","author":"Giuliani","year":"2017","journal-title":"Multiple Sclerosis Demyelinat. Disord."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0065","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3389\/fneur.2019.00788","article-title":"Prospective assessment of no evidence of disease activity-4 status in early disease stages of multiple sclerosis in routine clinical practice","volume":"10","author":"Guevara","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102076","article-title":"Inclusion of the symbol digit modalities test in a revised assessment of \u2018no evidence of disease activity-4 (NEDA-4)\u2019 in Latin-American patients with multiple sclerosis","volume":"42","author":"Guevara","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of multiple sclerosis: a review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578549_bb0080","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16421","article-title":"Global functional connectivity reorganization reflects cognitive processing speed deficits and fatigue in multiple sclerosis","volume":"32","author":"Hok","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0085","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1177\/1352458515616701","article-title":"Inclusion of brain volume loss in a revised measure of \u2018no evidence of disease activity\u2019 (NEDA-4) in relapsing-remitting multiple sclerosis","volume":"22","author":"Kappos","year":"2016","journal-title":"Multiple Sclerosis (Houndmills, Basingstoke, England)."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0090","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2025.578549_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104849","article-title":"Predictive models of multiple sclerosis-related cognitive performance using routine clinical practice predictors","volume":"76","author":"Labiano-Fontcuberta","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0100","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s40120-024-00599-5","article-title":"Sustained effectiveness and safety over time of teriflunomide in Chinese patients with relapsing multiple sclerosis in the Greater Bay Area of China: insights from real-world data","volume":"13","author":"Li","year":"2024","journal-title":"Neurol. Therapy."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0105","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fnhum.2018.00138","article-title":"Disrupted module efficiency of structural and functional brain connectomes in clinically isolated syndrome and multiple sclerosis","volume":"12","author":"Liu","year":"2018","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102826","article-title":"Disease modifying therapies in relapsing-remitting multiple sclerosis: a systematic review and network meta-analysis","volume":"20","author":"Liu","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.632917","article-title":"Increased within-network functional connectivity may predict NEDA status in fingolimod-treated MS patients","volume":"12","author":"Piervincenzi","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0120","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.nic.2024.03.008","article-title":"Network analysis in multiple sclerosis and related disorders","volume":"34","author":"Pontillo","year":"2024","journal-title":"Neuroimaging Clin. N. Am."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0125","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/1352458509104591","article-title":"Measures in the first year of therapy predict the response to interferon beta in MS","volume":"15","author":"R\u00edo","year":"2009","journal-title":"Multiple Sclerosis (Houndmills, Basingstoke, England)."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0130","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/14737175.2019.1555038","article-title":"Application of advanced MRI techniques to monitor pharmacologic and rehabilitative treatment in multiple sclerosis: current status and future perspectives","volume":"19","author":"Rocca","year":"2019","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0135","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41582-019-0170-8","article-title":"Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis","volume":"15","author":"Rotstein","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0140","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/jnnp-2023-331920","article-title":"Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS study","volume":"95","author":"Ruggieri","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2025.578549_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102690","article-title":"Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: a pilot study","volume":"48","author":"Saraste","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0150","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1016\/j.neuroimage.2011.11.032","article-title":"An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis","volume":"59","author":"Schmidt","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.jneuroim.2025.578549_bb0155","first-page":"1","article-title":"Postmovement Beta rebound in real and imagined movement","author":"Sisti","year":"2024","journal-title":"Mot. Control."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0160","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0165","first-page":"386","article-title":"GRETNA: a graph theoretical network analysis toolbox for imaging connectomics","volume":"9","author":"Wang","year":"2015","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40263-017-0482-4","volume":"32","author":"Weinstock-Guttman","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jneuroim.2025.578549_bb0175","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.acra.2024.01.032","article-title":"Interpretable and intuitive machine learning approaches for predicting disability progression in relapsing-remitting multiple sclerosis based on clinical and gray matter atrophy indicators","volume":"31","author":"Yan","year":"2024","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0180","first-page":"1713","article-title":"Brain volume loss is present in Japanese multiple sclerosis patients with no evidence of disease activity","volume":"39","author":"Yokote","year":"2018","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Itali. Soc. Clin. Neurophysiol."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0185","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.nrl.2020.07.022","article-title":"Incidence and prevalence of multiple sclerosis in China and other Asian countries","volume":"38","author":"Zhang","year":"2023","journal-title":"Neurologia (Engl Ed)"},{"key":"10.1016\/j.jneuroim.2025.578549_bb0190","first-page":"9","article-title":"Dimethyl fumarate reduces inflammation in chronic active multiple sclerosis lesions","author":"Zinger","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0195","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/jon.12411","article-title":"An observational study to assess brain MRI change and disease progression in multiple sclerosis clinical practice-the MS-MRIUS study","volume":"27","author":"Zivadinov","year":"2017","journal-title":"J. Neuroimag. Off. J. Am. Soc. Neuroimag."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jns.2018.03.028","article-title":"Effect of teriflunomide on gray and white matter brain pathology in multiple sclerosis using volumetric and diffusion-tensor imaging MRI measures","volume":"388","author":"Zivadinov","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2025.578549_bb0205","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1080\/03007995.2018.1458708","article-title":"No evidence of disease activity in patients receiving fingolimod at private or academic centers in clinical practice: a retrospective analysis of the multiple sclerosis, clinical, and magnetic resonance imaging outcomes in the USA (MS-MRIUS) study","volume":"34","author":"Zivadinov","year":"2018","journal-title":"Curr. Med. Res. Opin."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825000293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825000293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T01:20:26Z","timestamp":1740705626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572825000293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":41,"alternative-id":["S0165572825000293"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578549","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain network alteration was associated with \u2018no evidence of disease activity\u2019 status in patients with relapsing-remitting multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"578549"}}